Detalle Publicación

Results from the KarMMa clinical trial: secondary quality-of-life domains in patients (pts) with relapsed and refractory multiple myeloma (RRMM) treated with the BCMA-directed CAR T cell therapy Idecabtagene Vicleucel (ide-cel; bb2121)

Autores: Einsele, H.; Shah, N.; Delforge, M.; San Miguel Izquierdo, Jesús; Bertin, K. B.; Tahir, M. J.; Lewis, H. B.; Wang, J.; Braverman, J.; Campbell, T. B.; Dhanda, D.; Munshi, N. C.

Título de la revista: ONCOLOGY RESEARCH AND TREATMENT

ISSN: 2296-5270

Volumen: 44

Número: Supl. 2

Páginas: 206 - 208

Fecha de publicación: 2021

Impacto:

Google Scholar

Menú de navegación

Detalle Publicación

Results from the KarMMa clinical trial: secondary quality-of-life domains in patients (pts) with relapsed and refractory multiple myeloma (RRMM) treated with the BCMA-directed CAR T cell therapy Idecabtagene Vicleucel (ide-cel; bb2121)